Celldex Therapeutics shares owned by Columbia Wanger Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics shares owned by Columbia Wanger Asset Management
from 13F filings
Historical chart of Columbia Wanger Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Columbia Wanger Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by Columbia Wanger Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2017-12-31 | $31M | 11M | 2.84 |
2017-09-30 | $15M | 5.2M | 2.86 |
2017-06-30 | $21M | 8.5M | 2.47 |
2017-03-31 | $22M | 6.0M | 3.61 |
2016-12-31 | $22M | 6.2M | 3.54 |
2016-09-30 | $12M | 2.9M | 4.04 |
2016-06-30 | $23M | 5.3M | 4.39 |
2016-03-31 | $11M | 3.0M | 3.78 |
2015-12-31 | $57M | 3.6M | 15.68 |
2015-09-30 | $33M | 3.1M | 10.54 |
2015-06-30 | $65M | 2.6M | 25.22 |
2015-03-31 | $78M | 2.8M | 27.87 |
2014-12-31 | $58M | 3.2M | 18.25 |
2014-09-30 | $46M | 3.6M | 12.96 |
2014-06-30 | $59M | 3.6M | 16.32 |
2014-03-31 | $47M | 2.7M | 17.67 |
2013-12-31 | $41M | 1.7M | 24.21 |
More positions owned by Columbia Wanger Asset Management
View all positions for Columbia Wanger Asset Management